CCL2 and Epstein-Barr virus infection: In addition, EBV infection of primary human monocytes induces the release of the chemokine monocyte chemotactic protein 1 (MCP-1), and small interfering RNAs targeting TLR2 significantly reduce the chemokine response to EBV [9].